Weekly signal · GH · Healthcare

Guardant Health Inc (GH) rises 10.0% as weekly rebound meets mixed medium-term tape

The diagnostics stock’s latest weekly gain sits against a 69.3% twelve-week advance, but the four-week return remains negative.

Guardant Health Inc
Latest161.99 USD
1W move10.0%
Volume1.0x
TrendActive
Precision oncology diagnostics lab with blood testing equipment and a market data screen.

Market update

What happened

Guardant Health Inc (GH) closed the latest week at 161.99 USD, up 10.0% for the week ended July 31. The weekly price path over 52 weeks puts the move in the context of a much larger twelve-week gain of 69.3%.

Confirming evidence is constructive but not one-sided. The trend signal is active, Market Dynamics shows confirmation at 0.96, and Relative Strength is 51.7, while the four-week return is still -3.6%. Weekly active-mover data also flagged turnover at 1.6x, pointing to heavier participation behind the move.

Continue your research

Explore GH across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

GH coverage

Evidence context